Barinthus Biotherapeutics (BRNS)
NASDAQ:BRNS
Holding BRNS?
Track your performance easily

Barinthus Biotherapeutics (BRNS) Technical Analysis

84 Followers

Technical Sentiment

Overall Consensus
Neutral
9Bullish
6Neutral
7Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Barinthus Biotherapeutics’s (BRNS) Moving Averages Convergence Divergence (MACD) indicator is 0.04, suggesting Barinthus Biotherapeutics is a Buy.
Barinthus Biotherapeutics’s (BRNS) 20-Day exponential moving average is 1.38, while Barinthus Biotherapeutics’s (BRNS) share price is $1.37, making it a Buy.
Barinthus Biotherapeutics’s (BRNS) 50-Day exponential moving average is 1.35, while Barinthus Biotherapeutics’s (BRNS) share price is $1.37, making it a Buy.

Barinthus Biotherapeutics (BRNS) Pivot Points

Nov 14, 2024, 12:06 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.26
1.29
1.33
1.37
1.41
1.44
1.48
Fibonacci
1.29
1.32
1.34
1.37
1.40
1.41
1.44
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Barinthus Biotherapeutics (BRNS) Moving Averages

Nov 14, 2024, 12:06 AM
Period
Simple
Exponential
MA5
1.41Sell
1.40Buy
MA10
1.42Sell
1.40Sell
MA20
1.39Buy
1.38Buy
MA50
1.29Buy
1.35Buy
MA100
1.34Buy
1.47Sell
MA200
1.89Sell
1.95Sell
Barinthus Biotherapeutics’s (BRNS) 10-Day exponential moving average is 1.40, while Barinthus Biotherapeutics’s (BRNS) share price is $1.37, making it a Sell.
Barinthus Biotherapeutics’s (BRNS) 100-Day exponential moving average is 1.47, while Barinthus Biotherapeutics’s (BRNS) share price is $1.37, making it a Sell.
Barinthus Biotherapeutics’s (BRNS) stock price is $1.37 and Barinthus Biotherapeutics’s (BRNS) 50-day simple moving average is 1.29, creating a Buy signal.
Barinthus Biotherapeutics’s (BRNS) stock price is $1.37 and Barinthus Biotherapeutics’s (BRNS) 100-day simple moving average is 1.34, creating a Buy signal.
Barinthus Biotherapeutics’s (BRNS) stock price is $1.37 and Barinthus Biotherapeutics’s (BRNS) 200-day simple moving average is 1.89, creating a Sell signal.

Barinthus Biotherapeutics (BRNS) Technical Indicators

Nov 14, 2024, 12:06 AM
Name
Value
Implied Action
RSI (14)
52.70
Neutral
STOCH (9,6)
32.54
Neutral
STOCHRSI (14)
31.15
Neutral
MACD (12,26)
0.04
Buy
ADX (14)
26.10
Neutral
Williams %R
-52.00
Buy
CCI (14)
-17.06
Neutral
ATR (14)
0.10
-
Ultimate Oscillator
51.04
Neutral
ROC
2.19
Buy
Barinthus Biotherapeutics’s (BRNS) Relative Strength Index (RSI) is 52.70, creating a Neutral signal.
Barinthus Biotherapeutics’s (BRNS) Trend Strength Indicator (ADX) is 26.10, creating a Neutral signal.
Barinthus Biotherapeutics’s (BRNS) Commodity Channel Index (CCI) is -17.06, creating a Neutral signal.
Barinthus Biotherapeutics’s (BRNS) Price Rate of Change (ROC) is 2.19, creating a Buy signal.

FAQ

Is BRNS a Buy, Hold, or Sell?
Based on BRNS’s technical indicators, BRNS is a Hold.
    What is BRNS’s RSI (14)?
    BRNS’s RSI (14) is 52.70, which suggests BRNS is a Neutral.
      What is BRNS’s MACD?
      BRNS’s MACD is 0.04, which suggests BRNS is a Buy.
        What is BRNS’s 5-day moving average?
        BRNS’s 5-day moving average is 1.41, which suggests BRNS is a Sell.
          What is BRNS’s 20-day moving average?
          BRNS 20-day moving average is 1.39, which suggests BRNS is a Buy.
            What is BRNS’s 50-day moving average?
            BRNS’s 50-day moving average is 1.29, which suggests BRNS is a Buy.
              What is BRNS’s 200-day moving average?
              BRNS’s 200-day moving average is 1.89, which suggests BRNS is a Sell.
                What is BRNS’s Williams % R (14)?
                BRNS’s Williams % R (14) is -52.00, which suggests BRNS is a Buy.
                  What is BRNS’s CCI (14)?
                  BRNS’s CCI (14) is -17.06, which suggests BRNS is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis